Clinical Research to IB

I’m currently working as a clinical research coordinator for a global research team at a well-known cancer hospital. Although I initially planned to apply to medical school next cycle, my experiences in the field have led me to reconsider my career path. With a biology and economics undergraduate degree (from a well-known but non-target liberal arts college) - where I also managed a student investment fund - I have some modeling experience and a solid foundation in finance.

After careful reflection and discussions with several professionals, I’ve decided to pursue a role in healthcare investment banking. I've heard that starting in biotech equity research might offer the path of least resistance. In my current role, I’m responsible for collecting, cleaning, analyzing, and summarizing data for academic publications and grant proposals; I also interact with patients on a daily basis. Working within an international team has provided valuable insights into the complexities of pharmaceutical and biotech involvement in global clinical trials and drug sales. I do not, however, have an advanced degree

I’d appreciate any feedback from anyone who has made a similar transition or who knows someone with experience in this area. Specifically:

  1. Is starting in equity research a strategic move for someone with my background?
  2. Would pursuing an MBA significantly enhance my prospects, or are there viable alternative routes?
  3. What additional skills or experiences should I focus on developing during this transition?

Given the current economic climate, I do not plan on making any career moves for the next 18 months, so I’m taking this time to gather insights and better prepare my next steps.

Thank you in advance for your advice!

1 Comments
 

Deserunt sint atque velit molestias mollitia aliquam est accusantium. Dolor assumenda aliquid ea. Explicabo eum quam impedit et vitae. Reprehenderit debitis veritatis illo exercitationem.

Nesciunt mollitia dignissimos sed id pariatur nostrum ratione. Est facere eius perferendis. Architecto laudantium optio aliquam.

Quia quidem ut similique aut. Sit saepe est et veritatis. Molestiae sed est minus eos consequuntur est. Molestias odio sunt expedita possimus unde. Nemo consequatur cumque nostrum omnis nisi ab earum. Quia ea adipisci aliquid minima.

Adipisci magnam placeat corrupti tenetur. Et eum beatae omnis fugit omnis et. Corrupti ut dolorum ut nihil ratione dolorem.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • JPMorgan 01 98.4%
  • Guggenheim Partners 02 97.9%
  • Morgan Stanley 06 97.4%

Overall Employee Satisfaction

October 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Morgan Stanley 02 99.0%
  • Evercore 01 98.4%
  • Banco Santander 02 97.9%
  • BMO Capital Markets 13 97.4%

Professional Growth Opportunities

October 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 99.0%
  • Morgan Stanley 05 98.4%
  • Goldman Sachs 01 97.9%
  • JPMorgan No 97.4%

Total Avg Compensation

October 2026 Investment Banking

  • Vice President (16) $429
  • Associates (57) $264
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (28) $184
  • Intern/Summer Associate (16) $161
  • 1st Year Analyst (84) $151
  • Intern/Summer Analyst (76) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
GameTheory's picture
GameTheory
98.9
7
DrApeman's picture
DrApeman
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
numi's picture
numi
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”